A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
Breakthrough in Breast Cancer Treatment: Kelun Biotech's Sacituzumab Tirumotecan Shines at ESMO 2025